Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib.

Xia, Hongping; Lee, Kee Wah; Chen, Jianxiang; Kong, Shik Nie; Sekar, Karthik; Deivasigamani, Amudha; Seshachalam, Veerabrahma Pratap; Goh, Brian Kim Poh; Ooi, London Lucien; Hui, Kam M

Xia, Hongping; Lee, Kee Wah; Chen, Jianxiang; Kong, Shik Nie; Sekar, Karthik; Deivasigamani, Amudha; Seshachalam, Veerabrahma Pratap; Goh, Brian Kim Poh; Ooi, London Lucien; Hui, Kam M.

Afiliación

Xia H; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Lee KW; Department of Pathology, School of Basic Medical Sciences & Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
Chen J; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Kong SN; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Sekar K; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Deivasigamani A; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Seshachalam VP; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Goh BKP; Laboratory of Cancer Genomics, National Cancer Centre, Singapore, Singapore.
Ooi LL; Department of General Surgery, Singapore General Hospital, Singapore, Singapore.
Hui KM; Department of General Surgery, Singapore General Hospital, Singapore, Singapore.

Cell Death Discov ; 3: 17058, 2017.

Article en En | MEDLINE | ID: mdl-28900541

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Discov Año: 2017 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google